A study found a "significant" link between the frequency of chest X-ray referrals and improved survival rates for lung cancer ...

A groundbreaking study has revealed a significant link between the frequency of chest X-ray referrals from GPs and earlier ...

Final overall survival results show amivantamab plus lazertinib beat out osimertinib for first-line treatment of advanced ...

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

About 1 in 5 of all cancer deaths in the U.S. are lung cancer deaths. The overall 5-year survival rate (the percentage of people still living after 5 years with the disease) is 27%. The overall 5 ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

Lung Cancer Test Predicts Survival in Early Stages ... that found the drug AM-101 improves the effectiveness and survival rate of radiation ... Sep. 25, 2024 — Researchers have tested a ...

Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...

"Lung cancer ranks third in terms of new cases but second in terms of mortality in Vietnam. Of the over 24,000 new cases ...

Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy ...

Mar. 25, 2025 — Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor ...